- Home
- LNTH vs IESC Comparison
LNTH vs IESC Comparison
Compare LNTH & IESC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- IESC
- Stock Information
- Founded
- LNTH 1956
- IESC 1997
- Country
- LNTH United States
- IESC United States
- Employees
- LNTH N/A
- IESC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IESC Engineering & Construction
- Sector
- LNTH Health Care
- IESC Industrials
- Exchange
- LNTH Nasdaq
- IESC Nasdaq
- Market Cap
- LNTH 5.7B
- IESC 5.4B
- IPO Year
- LNTH 2015
- IESC 1998
- Fundamental
- Price
- LNTH $70.57
- IESC $350.41
- Analyst Decision
- LNTH Strong Buy
- IESC
- Analyst Count
- LNTH 5
- IESC 0
- Target Price
- LNTH $131.20
- IESC N/A
- AVG Volume (30 Days)
- LNTH 1.1M
- IESC 161.2K
- Earning Date
- LNTH 08-06-2025
- IESC 08-01-2025
- Dividend Yield
- LNTH N/A
- IESC N/A
- EPS Growth
- LNTH N/A
- IESC 47.54
- EPS
- LNTH 3.53
- IESC 13.08
- Revenue
- LNTH $1,536,699,000.00
- IESC $3,249,431,000.00
- Revenue This Year
- LNTH $4.57
- IESC $17.29
- Revenue Next Year
- LNTH $9.41
- IESC $11.11
- P/E Ratio
- LNTH $19.99
- IESC $26.78
- Revenue Growth
- LNTH 12.53
- IESC 17.84
- 52 Week Low
- LNTH $69.12
- IESC $129.16
- 52 Week High
- LNTH $118.21
- IESC $370.88
- Technical
- Relative Strength Index (RSI)
- LNTH 35.55
- IESC 65.68
- Support Level
- LNTH $70.40
- IESC $340.94
- Resistance Level
- LNTH $73.52
- IESC $370.88
- Average True Range (ATR)
- LNTH 2.48
- IESC 17.35
- MACD
- LNTH -0.27
- IESC 1.54
- Stochastic Oscillator
- LNTH 10.21
- IESC 74.20
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About IESC IES Holdings Inc.
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.